In vitro cell lines of primary and metastatic horse melanomas revealed expression of p53, while expression of the tumour suppressors p16 and PTEN was absent from the metastatic line 90, potentially implicating the latter pathways in disease progression. This evidence concerns the gene CDKN2A and melanoma.